Programme/Presentations 2018

Download Programme

Due to limitations regarding data volume, we cannot display video files embedded in the presentations.

Thursday, 6 December

* Competing for the MAC Award

09.00-10.35

CAD 1 | Lecture Hall B
Clinical and imaging variables in asymptomatic carotid patients with an increased late stroke risk – a critical review of the ESVS/ESC guidelines 2017

Chair: Gert de Borst, Holger Poppert
Barbara RantnerClinical variables with an increased late stroke risk
David SpenceSpontaneous embolisation on TCD and carotid plaque features
Peter RinglebSilent infarction and impaired cerebrovascular reactivity
Kosmas ParaskevasGrade of carotid stenosis and stenosis progression
Jonathan NadjiriMRI features of unstable carotid plaques
Jens GöttlerMulti-modal MRI identifies carotid stenosis patients with reduced cerebral blood flow and oxidative metabolism
Alison HallidayKeynote Lecture: CEA or CAS for asymptomatic carotid stenosis – which patients benefit most?

11.00-12.25

CAD 2 | Lecture Hall B
More news on carotid revascularization strategies and long-term outcomes in (a)symptomatic patients

Chair: Peter Ringleb, Kornelia Kreiser, Michael Kallmayer
Christos LiapisTotal occlusion of the internal carotid artery – not a benign condition
Kosmas ParaskevasOutcomes following eversion vs. conventional CEA in RCTs and observational studies – a systematic review
Armelle Meershoek*Long term outcomes of hybrid revascularization for extracranial symptomatic carotid artery tandem stenosis
Klaus MathiasEarly and one year data from the Scaffold (micromesh) CAS Trial
Sumaira MacDonaldControl of the microembolic burden of the carotid bifurcation lesion: comparison of various endovascular strategies
Ralf KolvenbachTranscarotid stenting with flow reversal: does the kind of stent matter?
Marc SchermerhornKeynote lecture: Transcarotid stenting (T-CAR) vs. CEA and transfemoral CAS in the SVS Vascular Quality Initiative

12.30-12.50

Special Lecture 1 | Lecture Hall B

Hans FörstlCognitive impairment and dementia in politicians

13.30-14.55

CAD 3 | Lecture Hall B
Carotid Stenosis Trialist Collaboration (CSTC) session

Chair: Alison Halliday, Claus Zimmer, Leo Bonati
Tilman ReiffStroke and TIA rates at one year in SPACE-2: BMT vs. CEA versus CAS in asymptomatic carotid stenosis
Richard BulbuliaCurrent status and perspectives of ACST-2, CREST-2, and ECST-2
Gert de BorstSafety of CEA and CAS in patients with a history of coronary heart disease in EVA-3S, SPACE, ICSS, and CREST
Christoph KnappichLocal anesthesia reduced the 30-day risk of stroke or death after symptomatic CEA – metaanalysis of five RCTs
Dylan Morris*Risk factors for major operative complications following asymptomatic CEA – 4.440 CEA from VACS, ACAS, ACST-1, and GALA
Evelien de Vries*Carotid stent failure as a predictor for periprocedural stroke or death after CAS – a substudy from ICSS
Leo BonatiKeynote Lecture: Immediate, intermediate, and long-term results after CEA and CAS in four RCTs on symptomatic carotid stenosis

15.00-15.25

Special Lecture 2 | Lecture Hall B

Christian BaarsDeadly superbugs from Pharma factories – an investigative report from the NDR Hamburg

17.25-18.30

CAD 4 | Lecture Hall C
Short communications on Carotid Artery Diseases

Chair: Kosmas Paraskevas, Tilman Reiff
Klaus MathiasCarotid artery aneurysms – what endovascular treatment can achieve
Vanessa PourierGadolinium enhancement and white matter lesions in extracranial carotid artery aneurysms
Astrid HovingThe performance of ultrasound particle image velocimetry in a carotid artery phantom with stent
Christoph SchäfferNon-invasive assessment of carotid plaque burden with tomographic ultrasound
Armelle MeershoekTreatment of internal carotid artery NEar occlusiON (NEON study): an individual patient data meta-analysis
Ihor KobzaThe choice of the optimal method of surgical correction of atherosclerotic carotid lesions
Peter KonstantiniukThe ASA classification predicts the ipsilateral stroke free survival in asymptomatic octogenarians with elective CEA
Evelien de VriesStandardization of semiautomatic tortuosity measurements in the carotid artery
Leonie FassaertDefining the awake blood pressure in patients undergoing CEA
Pedro Pinto SousaModerate (50%-69%) symptomatic carotis stenosis – what should we do?
Michael KallmayerEligibility to RCTs, do RCTs represent the real world?

* Competing for the MAC Award

09.00-10.40

AOR 1 | Lecture Hall C
Short communications on Aortic Diseases

Chair: Rebecka Hultgren, Benedikt Reutersberg, Jaroslav Pelisek
Ahmed EleshraDifferent zones (0-2) of hybrid de-branching endovascular aortic repair: outcomes and stroke analysis
Mikhail ChernyavskiyMid-term results of hybrid aortic arch repair
Pedro Pinto SousaAcute aortic syndrome – three typical case presentations
Arnaud KerzmannResults of left subclavian artery revascularization prior to elective TEVAR
Ahmad NagaCombined TEVAR and EVAR to treat thoracic Type I B endoleak and infrarenal AAA
Rita AugustoLate Type I A endoleak after EVAS: a unique challenge
Albert BuschAngiogenesis-inhibition and AAA
Shengliang LiuRole of neutrophil extracellular traps in AAA disease development and progression
Jasamine Coles-BlackAn easily reproducable 3D printed AAA model using open source digital tools
Pedro Pinto SousaEndovascular aneurysm repair in octogenarians
Jacinta CamposMycotic aortic aneurysm secondary to intravesical BCG instillation – is an endovascular approach effective?
Makhmud AkhmadEndovascular diagnostics and treatment of acute abdominal bleedings after upper GI surgery
Matthias TrennerIntraarterial CEUS – first experience with a new technique to detect early endoleaks in EVAR
Stefan OckertShort report: endovascular one stop shopping: EVAR + TAVI
Lars LönnComputer-controlled aortic occlusion (REBOA) for the treatment of cardiac arrest and bleedings
Konstantinos SpanosPre- and postoperative factors associated with the persistence of Endoleak Type II after EVAR in the first year of follow up
Dittmar BöcklerThe impact of low profile devices for TEVAR procedures
Piotr KasprzakEndograft explantation and aortic reconstruction in a patient with AAA rupture following EVAS (video presentation)

11.00-12.30

AOR 2 | Lecture Hall C
Dismantling AAAs – novel insights into disease mechanisms and future therapies

Chair: Lars Maegdefessel, Rebecka Hultgren
Rebecka HultgrenGender aspects in AAA disease
Marc BaileyVascular smooth muscle cell remodelling potentiates abdominal aortic aneurysm growth
Rachael ForsytheMulti-modality molecular and cellular imaging to predict AAA growth: towards personalised assessment of disease
Thorsten KesslerImplementing genetics into clinical practice in cardiovascular disease management
Wolf Eilenberg*The association of neutrophil activation markers with morphological features of AAA
Markus Wagenhäuser*Nicotine is a regulator of segmental aortic stiffening – implications for AAA development
Valentina Paloschi*Aorta-on-a-chip: a novel tool to gain molecular insights into aneurym disease

13.30-15.00

AOR 3 | Lecture Hall C
Biomechanical simulation of aortic aneurysms

Chair: Wolfgang Wall, Michael Gee, Markus Kleemann
Thomas GasserPredicting three-dimensional AAA growth from CT-A images
Stephane AvrilPatient-specific numerical simulation of endovascular aneurysm repair
Michael GeeIn Silico EVAR for Abdominal Aortic Aneurysms
Tina CohnertAdvances in biomechanical and structural AAA wall analysis
Joy RoyBiomechanical modeling of AAA growth and rupture – a clinical perspective
Benedikt ReutersbergThe SCAN study reveals that cardiovascular patients should be ultrasound-screened for AAA

* Competing for the MAC Award

15.40-17.05

PAD 1 | Lecture Hall B
Innovative imaging and below-the-knee treatment modalities

Chair: Jonathan Nadjiri, Anders Wanhainen
Jean-Paul de VriesDETECT-PAD II: computerized and patient specific model to determine pressure gradients in borderline stenosis with MRA/CTA
Jos van den BergZero contrast procedure by use of unenhanced MRA and CO2 angiography
Michael Rasper3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities
Jean-Paul de VriesThe REPEAT study: validation of perfusion angiography measurements for below-the-knee arteries in critcal limb ischaemia
Marianne BrodmannEarly results from a RCT on below-the-knee drug-eluting balloons
Achim NeufangSurgical arterialisation of the plantar venous system for foot salvage after failed endovascular or operative revascularisation

17.25-18.30

PAD 2 | Lecture Hall B
Peripheral and mesenteric vascular emergencies

Chair: Achim Neufang, Alexander Zimmermann
Anders WanhainenOpen or endovascular revascularization in the treatment of acute lower limb ischaemia
Kerstin StoklasaOutcomes of a consecutive series of 708 patients with acute limb ischaemia – a single center report from Munich
Heli Järve*Acute mesenteric ischaemia: irreversible vs. reversible bowel damage – a single center experience
Shelby Cooper*Mesenteric vascular injuries in trauma: a National Trauma Data Bank (NTDB) study from the US
Adel Hussein KamhawyArterial injury associated with pediatric supracondylar humerus fracture – exploration or observation?
Ralf KolvenbachKeynote Lecture: Civilian and pediatric vascular trauma management – an overview

13.30-14.15

Mini-Symposium 1 | Conference Room 1
Advance Therapy Outcomes in fenestrated and branched EVAR (Industry Sponsored)

Stefan OckertThe workflow during complex EVAR – mobile vs. fixed C-Arms (with a focus on ARTIS Pheno)
Eric VerhoevenThe workflow during FEVAR in the hybrid OR with fusion imaging (syngo EVAR Guidance)
Dittmar BöcklerIntraoperative 3D assessment of FEVAR and BEVAR – EVAR guidance and distorsion correction

15.30-17.00

SPECIAL SESSION 1 | Lecture Hall C
Hot topics in radiation protection 2018

Chair: Alexander Oberhuber, Thomas Schmitz-Rixen, Christos Liapis
Tina CohnertAdvanced radiation protection in the hybrid OR with Zero Gravity
Dittmar BöcklerPractical tips in radiation protection for surgical staff in the hybrid OR
Heiko WendorffMid-term effects of an Intensive radiation-protectionTraining on the IntraoperativeX-ray-radiation exposure in the hybrid OR
Stefan OckertRadiation exposure during C-arm supported EVAR with the Siemens Pheno system
Bijan ModaraiRisks associated with protracted low dose radiation exposure
Dittmar BöcklerEvidence of radiation induced cataracts and brain tumors
Stefan OckertEVAS might be associated with a decrease in intraoperative radiation dose as compared to EVAR

Friday, 7 December

* Competing for the MAC Award

08.30-10.05

CAD 5 | Lecture Hall C
Carotid Artery Disease (CAD) – from genes to therapies

Chair: Jan Nilsson, Lars Maegdefessel
Martin DichgansStroke Genetics: discovery, biology, and clinical implications
Andrew BakerTargeting SMCs through ncRNA modulation
Jan NilssonFactors associated with progression of carotid disease in high risk patients
Judith SluimerInterplay of oxygen sensors, inflammation, and cholesterol metabolism in atherosclerosis
Pirkka VikatmaaMorphology and histology of silent and symptom-causing atherosclerotic carotid plaques – the Helsinki CEA Study 2
Hanna Winter*Long non-coding RNA NUDT6 regulates fibrous cap thickness in advanced atherosclerosis
Joachim Schmidt*Expression of human somatostatin receptors and glucose transporters in carotid artery stenosis and aneurysms

10.30-11.40

CAD 6 | Lecture Hall C
Carotid plaque burden and vulnerability – assessment and clinical impact

Chair: Eva Bartels, Richard Bulbulia
David SpenceKeynote Lecture: Carotid plaque burden predicts future cardiovascular events – why and how I do it!
Steven RogersWill carotid plaque volume assessed by 3D tomographic ultrasound be an alternative indicator for CEA or CAS?
Holger PoppertHow to detect and to stratify DUS findings at the carotid bifurcation (echolucency, ulceration, etc.)
Marjolijn Rots*Correlation between plaque characteristics and presence of preoperative white matter lesions in patients undergoing CEA
Igor KoncarTAXINOMISIS – a multidisciplinary EU project on stratification of patients with carotid artery disease

* Competing for the MAC Award

08.30-10.05

AOR 4 | Lecture Hall B
The new AAA guidelines from the SVS, ESVS, Germany, and UK (NICE)

Chair: Julian Scott, Matthias Trenner, Eric Verhoeven
Anders WanhainenKeynote Lecture: The new ESVS guidelines – what is new and what is different from the 2017 SVS AAA guidelines?
Sebastian DebusAre there any different recommendations in the 2018 AAA guidelines from the German Vascular Society (DGG)?
Mike WyattChanges to the management of patients with AAA in the UK: is NICE out of touch with worldwide best practice?
Athanasios GiannoukasSome small AAAs (4.5-5.5 cm) should be treated - how to select them?
Thomas Schmitz-RixenHow valid is the 5/5.5cm diameter threshold for AAA repair and do we need new RCTs to improve the evidence?
Igor KoncarMorphological predictors of an increased AAA rupture risk
Clark ZeebregtsAccuracy of routine endoscopy diagnosing colonic ischaemia after AAA repair – a meta-analysis

10.30-12.00

AOR 5 | Lecture Hall B
Endoleak prevention and management in complex aortic aneurysms

Chair: Ralf Kolvenbach, Mike Wyatt
Lars LönnQualitative systematic review of studies reporting on re-interventions after elective EVAR
Marc SchermerhornSelected Type I and III EL at completion of FEVAR are safe to observe
Colin BicknellEndovascular strategies for treatment of Type I EL in EVAR
Albert BuschExpansion and atrophy – aortic wall development after EVAR with endoleak Type II
Jean-Paul de VriesDeterminants of successful and unsuccessful deployment of EndoAnchors in hostile necks – evaluation of >300 implants
Athanasios GiannoukasExpanding the borders in the treatment of pararenal AAAs with Ch-EVAS
Clark ZeebregtsThe GLOBAL FACT Registry: a world-wide registry with core lab analysis of fenestrated Anaconda for complex aneurysms
Alexander OberhuberThe (JOTEC®) iliAc BRAnch device for exclusion of Hypogastric Artery aneurysMs – ABRAHAM trial

12:30-12:45

SPECIAL LECTURE 3 | Lecture Hall C

Julian ScottSarcopenia and outcomes in vascular surgery

13.00-14.20

AOR 6 | Lecture Hall B
Ascending aorta and aortic arch

Chair: Dittmar Böckler, Piotr Kasprzak
Martin CzernyThe EACTS/ESVS expert consensus document on thoracic aortic pathologies affecting the aortic arch
Ralf KolvenbachStatus of ascending aortic stent grafts in true aneurysms
Martin CzernyTotal endovascular treatment of aortic arch pathologies using branched endografts
Celia RigaContact force assessment in the arch during TEVAR: how do different graft designs perform?
Jonathan NadjiriAssessment of flow-displacement and wall-shear-stress by 4D aortic MRA
Ali ShahriariRepair of acute DeBakey I dissections using a novel dissection – specific arch hybrid graft (AMDS)

14.50-16.40

AOR 7 | Lecture Hall B
Thoracic/Thoraco-abdominal aneurysm and dissections

Chair: Tina Cohnert, Alexander Zimmermann
Dittmar BöcklerPrevalence of the CTA-based morphological DISSECT predictors in uncomplicated Stanford Type B aortic dissection
Igor KoncarEarly TEVAR in acute Type B dissection
Bijan ModaraiContemporary treatment of Type B aortic dissection: is there a need for a disease specific approach to endografting?
Eric VerhoevenTreatment of chronic aortic dissections with fenestrated and branched endografts
Celia RigaFrozen elephant trunk techniques for chronic Type B dissections
Athanasios KatsargyrisInner branches as an additional option besides fenestrations and branches in TAAA branched grafting
Colin BicknellPrevention and revision of TEVAR utilising EndoAnchors to reduce and treat endoleak
Sebastian DebusThe SPIDERgraft: can this novel technique decrease complications after thoracoabdominal repair?
Christos LiapisSide effects of TEVAR and EVAR on the heart – myth or reality?
Christian ReepsRole of abdominal and thoracic aortic surgery in radical cancer resection

* Competing for the MAC Award

12.45-14.30

PAD 3 | Lecture Hall C
Challenges in PAD – long and calcified lesions, in-stent-restenosis, CLI, and wound healing

Chair: Marianne Brodmann, Heiko Wendorff, Adel Hussein Kamhawy
Thomas ZellerKeynote Lecture: Technological advances in the endovascular treatment of calcified peripheral lesions?
Pirkka VikatmaaMultimodal revascularization strategies in CLI – the Helsinki approach
Jean-Paul de Vries2 year results of the RAPID trial – RCT comparing Legflow DCB with Supera stenting vs. Supera alone for SFA lesions
Gunnar Tepe2 year results of the COPA CABANA RCT of DCB vs. PTA for femoro-popliteal in-stent restenosis
Jos van den BergCurrent status of in-stent restenosis treatment in the SFA
Thomas ZellerEffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA
Martin Lawaetz*Is stenting of the superficial femoral artery as good as bypass surgery? Data from the Danish Vascular Registry
Alexander ZimmermannThe SVS objective performance goals are achievable for surgical therapy in a consecutive CLI all-comers cohort
Alexander Gombert*Closed-incision negative-pressure therapy reduces vascular surgical site infections: the randomized AIMS trial
George GeroulakosTime of complete healing of leg ulcers following revascularization for critical limb ischaemia

14.50-15.50

PAD 4 | Lecture Hall C
Update on lipid-lowering therapy in carotid and peripheral atherosclerosis

Chair: Christine Espinola-Klein, Richard Bulbulia
David SpenceBest medical treatment for asymptomatic carotid disease – optimal LDL levels are achievable!
Richard BulbuliaIntensive lipid-lowering for plaque stabilisation and regression? Implications for surgeons and our patients!
Barbara RantnerCardiovascular morbidity and mortality in patients with intermittent claudication – medical long-term intervention is a MUST
Mark SchermerhornSurvival after lower extremity revascularization for critical limb-threatening ischaemia (CLTI) is better with high-dose statin
Thomas StadlbauerPCSK9 inhibitor evolocumab in patients with and without PAD – even better than statins?

15.50-16.40

PAD 5 | Lecture Hall C
Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD

Chair: Barbara Rantner, Klaus Mathias
Christine Espinola-KleinUpdate on periprocedural and long-term antithrombotic management in PAD
Thomas StadlbauerPlatelet inhibition PLUS low-dose anticoagulation – a new paradigm for all PAD patients?
Michael SpannaglHow to assess and individualize platelet inhibition in PAD
Marianne BrodmannCardiovascular outcomes after lower extremity endovascular or surgical revascularization – the EUCLID trial

17.00-18.00

PAD 6 | Lecture Hall C
Short communications on Peripheral Arterial Disease

Chair: Christoph Knappich, Christian Reeps, Mohamed Ayman Nagib
Dmitry DombrovskyTransplantation of stem cells of different origin for the treatment of lower limb ischaemia
Akshitha KesharajuSarcopenia as predictor of mortality and morbidity following major lower limb amputation
Mohamed Ayman NagibTransbrachial approach as an alternative method in the management of aortoiliac occlusive arterial diseases
Sabine Dallmann-SieberAcute occlusions of the infrarenal aorta – single-center experience of 68 patients in a 14-year period
Bianca Marinelli TeixeiraRare atherosclerotic aneurysms of the dorsalis pedis artery in young women – case reports and literature review
Sohiel NagibCost-effectiveness of CO2 as contrast medium for the endovascular treatment of PAOD in renal dysfunction
Yuriy LevchakAdventitial cystic disease of the lower extremity main vessels

12.30-13.30

Mini-Symposium 2 | Conference Room 1
The venous challenge – successful strategies to treat venous lesions (Industry Sponsored)

Tobias SteinkeThe endovascular option for AV-fistula creation
Tobias SteinkeHow to treat AV-fistula stenosis best
Houman JalaieThe right way to treat chronic obstructive venous lesions – tips and tricks in diagnostic, indication, and treatment
Mohammad E. BarbatiWhat did we learn from the "Attract"-Study?

15.00-16.00

Mini-Symposium 3 | Conference Room 1
Acute Type A Dissections: changing paradigms? (Industry Sponsored)


Chair: Ali Shahriari, Martin Czerny

17.00-18.05

SPECIAL SESSION 2 | Lecture Hall B
Team training, simulation, and augmented reality in the hybrid OR

Chair: Colin Bicknell, Albert Busch
Mark Kaschwich*A modular approach for an endovascular training environment using rapid prototyping as part of the Nav-EVAR project
Markus KleemannAugmented reality for navigated EVAR
Thomas LiebigMetric-based virtual reality simulation – a paradigm shift in training for severe stroke
Celia RigaAn optimised team training for EVAR & TEVAR – how do you set it up and what is the evidence?
Matthias TrennerThe volume-outcome effect in AAA surgery indicates that trained teams perform better in elective and emergency settings
Heiko Wendorff3D simulation in the Hybrid OR – just a gimmick or a valuable tool?

Saturday, 8 December

09.00-10.00

VEN 1 | Lecture Hall B
Short communications on Venous Diseases

Chair: Claus-Georg Schmedt, Rolf Weidenhagen
Luís GamasVenous stenting: initial experience and follow up in a Portuguese center
Mohamed Ayman NagibLaser crossectomy vs. anterior accessory saphenous vein laser ablation for anterior accessory saphenous vein reflux
Sohiel NagibAcute upper extremity deep vein thrombosis (DVT) – indications and effectiveness of superior caval filters
Mohamed IsmailRole of inferior vena cava filter insertion prior to thrombolysis of acute iliofemoral deep venous thrombosis
Mangesh TarteInferior caval obstruction – limited role of endovenous therapy
Andrij NykonenkoDiagnostic management of the „nutcracker syndrome“
Mangesh TarteCombined role of laser ablation, ethanol embolisation, and foam sclerotherapy in the treatment of venous malformations
Adel Hussein KamhawySurgical management of high- and low-flow vascular malformations

10.00-11.05

VEN 2 | Lecture Hall B
Acute and chronic deep vein thrombosis (DVT) – conservative and recanalizing strategies

Chair: Jan Beyer-Westendorf, Karin Pfister
Armando MansilhaTreating acute DVT with DOACs – advances and challenges
Viktor PavlychenkoSurgical vs. conservative treatment of deep venous thrombosis: follow-up and quality of life
Stefan OckertQuality of life and post-thrombotic syndrome after surgical thrombectomy of acute iliofemoral DVT
George GeroulakosComplications of endovascular treatment of May-Thurner syndrome
Houman JalaieTechnical advances in recanalizing chronic venous obstructions – „skipped Y“ and femoral endophlebectomy

11.30-13.00

VEN 3 | Lecture Hall B
New developments in lower leg varicose vein disease

Chair: Armando Mansilha, Houman Jalaie
Reshaabi SrinanthalogenA novel view at the pathogenesis of varicose veins: proteomic analysis
Jan Beyer-WestendorfSUPRISE – a RCT on thromboembolic complications in superficial-vein thrombosis under Rivaroxaban or Fondaparinux
Tobias HirschInterventional treatment of perforator veins
Christian ReepsIs high ligation still an option in superficial-vein thrombosis close to the sapheno-femoral junction?
Thomas PröbstleCurrent status of non-termal/non-tumescent saphenous ablation
Claus-Georg SchmedtLEVEL-2 trial – Endovenous Laser Therapy (EVLT) with long wavelength (1940nm) and reduced energy density
Tobias HirschWhat do we know about the allergenic risk of adhesive vein treatments?

13.30-14.45

VEN 4 | Lecture Hall B
The 2015 ESVS guidelines on chronic venous diseases – a critical review

Chair: Thomas Pröbstle, Uta Werthern
Armando MansilhaKeynote lecture: Why the current international guidelines are not always accurate to define the best technique for varicose veins
Mike WyattMultimodal treatment of small saphenous vein reflux
Rolf WeidenhagenMultimodal treatment of greater saphenous vein reflux
Karin PfisterPeriprocedural and long-term compression therapy – indications, evidence, and outcomes
Houman JalaieThe postthrombotic syndrome – prevention and recanalizing treatment strategies